KI
Khalidul Islam
About Khalidul Islam
Data last updated:
Khalidul Islam is a Director at Adenom Pharmaceuticals Private Limited (since 2022) and Director at Walloper Pharmaceuticals Private Limited (since 2018). The companies operate in Chemicals and Trading. The largest current company by reported revenue is Adenom Pharmaceuticals Private Limited at ₹4.7 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Adenom Pharmaceuticals Private Limited U24100DL2022PTC395003 | Director | 11 Mar 2022 | 2022 | ₹4.7 Lakh (FY 2023) | Active |
| Walloper Pharmaceuticals Private Limited U51909DL2018PTC331796 | Director | 02 Apr 2018 | 2018 | Active |
Board colleagues of Khalidul Islam
| Name | DIN | Company | Designation |
|---|---|---|---|
| Faaiz Mazhari | 08967283 | Adenom Pharmaceuticals Private Limited | Director |
| Nehal Hassan | 08082346 | Walloper Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Khalidul Islam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Khalidul Islam
Khalidul Islam currently holds 2 directorships: Adenom Pharmaceuticals Private Limited (Director, since 11 Mar 2022, revenue ₹4.7 Lakh (FY 2023)); Walloper Pharmaceuticals Private Limited (Director, since 02 Apr 2018).
Khalidul Islam was first appointed on 02 Apr 2018 as Director at Walloper Pharmaceuticals Private Limited. The most recent appointment on record is 11 Mar 2022 at Adenom Pharmaceuticals Private Limited.
The current boards of Khalidul Islam's companies include Faaiz Mazhari (Adenom Pharmaceuticals Private Limited), Nehal Hassan (Walloper Pharmaceuticals Private Limited).